More than two decades ago, Muller et al.,40 using a cell bioassay, noted a moderate reduction in serum concentrations of TGF‐β1 in sIgAD patients, and these correlated negatively with the numbers of CD19+ B cells.38 Here, TGFB1 is linked to selective IgA deficiency disease.